All stakeholders have a role in ensuring Canada can attract research and new medicine launches as we rebuild from the pandemic. In this context, LSO has provided a number of general recommendations and considerations to help guide the PMPRB’s approach for its interim guidelines period and beyond. Read LSO’s submission…
Penny Mungal
External Affairs Manager Operations – downtown Toronto, Ontario Make a difference with Life Sciences Ontario (LSO) www.lifesciencesontario.ca Who we are and what we do: Life Sciences Ontario is a member-driven organization that represents and promotes the province’s vibrant and diverse life sciences sector. LSO collaborates with governments, academia, industry, and…
Is Canada losing its status as a priority medicine launch country? Canada has long been considered a priority country for new medicine launches. However, ongoing, and unpredictable changes to the pharmaceutical policy environment have caused market uncertainty, which has impacted Canada’s ability to maintain this status. To help inform and…
Guelph/Toronto, 25 May 2022 – Ontario’s life sciences sector and Canada’s Food & Agri-Tech Engine have agreed to collaborate in support of innovation by signing a Memorandum of Understanding (MOU). Life Sciences Ontario, which represents Ontario’s pharmaceutical, medical device, agri-food and agri-tech, biotech and medicinal cannabis industries, has joined Bioenterprise Canada as a Knowledge…